摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-硝基-4-氯三氟甲氧基苯 | 588-09-0

中文名称
3-硝基-4-氯三氟甲氧基苯
中文别名
1-氯-2-硝基-4-(三氟甲氧基)苯;2-氯-5-三氟甲氧基硝基苯
英文名称
1-chloro-2-nitro-4-(trifluoromethoxy)benzene
英文别名
4-(trifluoromethoxy)-2-nitro-1-chlorobenzene
3-硝基-4-氯三氟甲氧基苯化学式
CAS
588-09-0
化学式
C7H3ClF3NO3
mdl
——
分子量
241.554
InChiKey
WMEHRJJXMQRTOU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    247℃
  • 密度:
    1.572
  • 闪点:
    103℃

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    55
  • 氢给体数:
    0
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2909309090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:f54ce374d07df34091b683704ecd074e
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-Chloro-2-nitro-4-(trifluoromethoxy)benzene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-Chloro-2-nitro-4-(trifluoromethoxy)benzene
CAS number: 588-09-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H3ClF3NO3
Molecular weight: 241.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-硝基-4-氯三氟甲氧基苯potassium carbonate氯化铵N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 44.0h, 生成 5,7-dimethyl-N-(2-(pyrrolidin-1-yl)-5-(trifluoromethoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
    参考文献:
    名称:
    具有中等至缓慢作用红细胞阶段活性的 2-(N-苯基甲酰胺) 三唑并嘧啶抗疟药的优化
    摘要:
    疟疾是由从该属的寄生虫毁灭性的寄生虫病疟原虫。据报道,所有临床上可用的抗疟药都存在治疗耐药性,威胁到我们控制疾病的能力,因此持续需要开发新型抗疟药。为了实现这一目标,我们从 Janssen Jumpstarter 库的高通量筛选中针对恶性疟原虫的无性阶段鉴定了 2-(N-苯基甲酰胺)三唑并嘧啶类寄生虫。在这里,我们描述了已识别类别的结构活性关系和无性阶段活性的优化,同时保持对人 HepG2 细胞系的选择性。本研究中最有效的类似物显示出对恶性疟原虫多药耐药菌株和诺氏疟原虫无性寄生虫的等效活性。无性阶段表型研究确定三唑并嘧啶类在滋养体阶段捕获寄生虫,但这些寄生虫很可能在第二个无性周期之前仍然具有代谢活性,因此具有中度至缓慢的作用开始。在体外观察到中心羧酰胺的非 NADPH 依赖性降解和低水溶性ADME 分析。一个重大挑战仍然是纠正这些缺陷,以进一步推进 2-( N-苯基甲酰胺) 三唑并嘧啶支架
    DOI:
    10.1016/j.bioorg.2021.105244
  • 作为产物:
    参考文献:
    名称:
    邻氨基三氟甲氧基苯和间氨基三氟甲氧基苯联产制备方法
    摘要:
    本发明公开了一种邻氨基三氟甲氧基苯和间氨基三氟甲氧基苯联产制备方法,属于精细化工技术领域。该制备方法采用如下步骤:①硝化反应:4‑氯‑三氟甲氧基苯经硝化反应得到4‑氯‑2‑硝基‑三氟甲氧基苯和4‑氯‑3‑硝基‑三氟甲氧基苯的混合物;②还原和脱氯:4‑氯‑2‑硝基‑三氟甲氧基苯和4‑氯‑3‑硝基‑三氟甲氧基苯的混合物经还原和脱氯得到邻氨基三氟甲氧基苯和间氨基三氟甲氧基苯。③精馏分离:通过精馏,将邻氨基三氟甲氧基苯和间氨基三氟甲氧基苯进行分离,从而实现联产。本发明成本低,收率高,同时得到两个有用的化工产品,工艺简单,工业化生产易实现。
    公开号:
    CN112159329B
点击查看最新优质反应信息

文献信息

  • [EN] DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES<br/>[FR] [4-(5-AMINOMÉTHYL-PHÉNYL)-PIPÉRIDIN-1-YL]-1H-INDOL-3-YL]-MÉTHANONES DISUBSTITUÉES
    申请人:SANOFI AVENTIS
    公开号:WO2011022449A1
    公开(公告)日:2011-02-24
    The present invention extends to the compound of formula I: or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed to the use of a compound of formula I as an inhibitor of tryptase, comprising introducing the compound into a composition comprising tryptase. In addition, the present invention is directed to the use of a compound of formula I for treating a patient suffering from, or subject to, a physiological condition in need of amelioration of an inhibitor of tryptase comprising administering to the patient a therapeutically effective amount of the compound of Claim 1. The present invention is directed also to the preparation of a compound of formula I.
    本发明涉及到式I的化合物:或者该化合物的前药、药用可接受的盐或溶剂。此外,本发明涉及一种包括式I化合物的药物组合物,以及药用可接受的载体的药学有效量。此外,本发明涉及将式I化合物用作色氨酸蛋白酶抑制剂的用途,包括将该化合物引入含有色氨酸蛋白酶的组合物中。此外,本发明还涉及将式I化合物用于治疗患有或患有需要改善色氨酸蛋白酶抑制剂的生理状况的患者的用途,包括向患者施用权利要求1中的化合物的治疗有效量。本发明还涉及制备式I化合物。
  • Silver-Mediated Trifluoromethoxylation of (Hetero)aryldiazonium Tetrafluoroborates
    作者:Yu-Ming Yang、Jian-Fei Yao、Wei Yan、Zhuangzhu Luo、Zhen-Yu Tang
    DOI:10.1021/acs.orglett.9b03000
    日期:2019.10.4
    Here we report a silver-mediated trifluoromethoxylation of (hetero)aryldiazonium tetrafluoroborates by converting an aromatic amino group into an OCF3 group. This method, which can be considered to be a trifluoromethoxylation variation of the classic Sandmeyer-type reaction, uses readily available aryl and heteroaromatic amines as starting materials and AgOCF3 as trifluoromethoxylating reagents. The
    在这里,我们报道了通过将芳香族氨基基团转换为OCF 3基团,银介导的(杂)芳基重氮四氟硼酸酯的三氟甲氧基化作用。该方法被认为是经典Sandmeyer型反应的三氟甲氧基化反应形式,它使用容易获得的芳基和杂芳族胺作为原料,并使用AgOCF 3作为三氟甲氧基化试剂。广泛的底物范围和简单,温和的反应条件使该转化成为构建芳基-OCF 3键的有价值的方法。
  • Lonidamine analogues and their use in male contraception and cancer treatment
    申请人:Georg I. Gunda
    公开号:US20060047126A1
    公开(公告)日:2006-03-02
    Novel compounds useful for inhibiting spermatogenesis and cancer treatment, and in particular as inhibitors of heat shock proteins and/or elongation factor 1 alpha.
    用于抑制精子生成和癌症治疗的新化合物,特别是作为热休克蛋白和/或延长因子1α的抑制剂。
  • 一种芳胺三氟甲氧基化反应的方法
    申请人:中南大学
    公开号:CN108530240B
    公开(公告)日:2020-06-23
    本发明提供了一种由芳胺化合物合成芳基三氟甲氧基化合物的方法,该方法是将芳胺进行重氮化反应,生成的芳基重氮盐与三氟甲氧基银的乙腈溶剂一锅法反应,得到相应的芳基三氟甲氧基产物,得到的产物产率高,过程简单。
  • Herbicidal ethers
    申请人:E. I. Du Pont de Nemours and Company
    公开号:US04192669A1
    公开(公告)日:1980-03-11
    Ethers, such as 2-[[4-[4-(trifluoromethoxy)phenoxy]phenoxy]]propanoic acid, methyl ester, useful for control of weeds.
    乙醚,如2-[[4-[4-(三氟甲氧基)苯氧基]苯氧基]]丙酸,甲酯,用于控制杂草。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐